Data gathered: November 18
AI Stock Analysis - DaVita (DVA)
Analysis generated June 4, 2024. Powered by Chat GPT.
DaVita Inc. is a leading provider of kidney dialysis services. With a mission to provide top-notch quality care for patients with chronic kidney failure or end-stage renal disease, DaVita operates kidney dialysis centers and provides related lab services primarily in the United States. In recent years, they have expanded their operations and focused on integrating innovative healthcare solutions to enhance patient outcomes.
Stock Alerts - DaVita (DVA)
 |
DaVita | October 30 Price is down by -7% in the last 24h. |
|
DaVita | September 18 Insider Alert: Rodriguez Javier is selling shares |
|
DaVita | September 2 Job postings are down by -57.9% in the last couple of days. |
|
DaVita | September 1 Job postings are down by 58.3% in the last couple of days. |
Alternative Data for DaVita
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3,781 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 881,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 74 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 950 | Sign up | Sign up | Sign up |
| Facebook Followers | 123,310 | Sign up | Sign up | Sign up |
| Instagram Followers | 21,815 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,117 | Sign up | Sign up | Sign up |
| Twitter Followers | 14,881 | Sign up | Sign up | Sign up |
| Twitter Mentions | 5 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 43,100 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 54 | Sign up | Sign up | Sign up |
| Linkedin Employees | 36,234 | Sign up | Sign up | Sign up |
About DaVita
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
| Price | $157.41 |
| Target Price | Sign up |
| Volume | 940,380 |
| Market Cap | $13.2B |
| Year Range | $126.11 - $165.19 |
| Dividend Yield | 0% |
| PE Ratio | 17.28 |
| Analyst Rating | 0% buy |
| Industry | Medical Care Facilities |
In the news
 |
Is Wall Street Bullish or Bearish on DaVita Stock?November 17 - Biztoc.com |
 |
DaVita: Better Results Than Fresenius, But A 'Hold' Due To ValuationNovember 13 - SeekingAlpha |
 |
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global HealthNovember 11 - Yahoo |
 |
Janney Montgomery Scott LLC Has $4.03 Million Stock Position in DaVita Inc. (NYSE:DVA)November 10 - ETF Daily News |
|
DaVita Inc. (NYSE:DVA) Shares Sold by Gulf International Bank UK LtdNovember 9 - ETF Daily News |
|
Private Advisor Group LLC Sells 1,053 Shares of DaVita Inc. (NYSE:DVA)November 9 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 3.26B | 581M | 2.68B | 215M | 722M | 2.500 |
| Q2 '24 | 3.19B | 544M | 2.64B | 223M | 682M | 2.500 |
| Q1 '24 | 3.07B | 550M | 2.52B | 240M | 671M | 2.260 |
| Q4 '23 | 3.15B | 623M | 2.52B | 151M | 585M | 1.620 |
| Q3 '23 | 3.12B | 565M | 2.56B | 247M | 684M | 2.620 |
Insider Transactions View All
| Rodriguez Javier filed to sell 837,835 shares at $165.1. September 17 '24 |
| Rodriguez Javier filed to sell 887,835 shares at $162.9. September 17 '24 |
| ACKERMAN JOEL filed to sell 106,741 shares at $155. August 29 '24 |
| Rodriguez Javier filed to sell 897,716 shares at $155.9. August 28 '24 |
| ACKERMAN JOEL filed to sell 111,481 shares at $155.1. August 29 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gerald Moran Republican |
Jan 17, 24 | Sell | $1K - $15K |
| Gerald Moran Republican |
Jan 17, 24 | Sell | $1K - $15K |
| Thomas Tuberville Republican |
Jan 12, 24 | Sell | $1K - $15K |
Read more about DaVita (DVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of DaVita?
The Market Cap of DaVita is $13.2B.
What is DaVita's PE Ratio?
As of today, DaVita's PE (Price to Earnings) ratio is 17.28.
What is the current stock price of DaVita?
Currently, the price of one share of DaVita stock is $157.41.
How can I analyze the DVA stock price chart for investment decisions?
The DVA stock price chart above provides a comprehensive visual representation of DaVita's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DaVita shares. Our platform offers an up-to-date DVA stock price chart, along with technical data analysis and alternative data insights.
Does DVA offer dividends to its shareholders?
As of our latest update, DaVita (DVA) does not offer dividends to its shareholders. Investors interested in DaVita should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of DaVita?
Some of the similar stocks of DaVita are Encompass Health, Brookdale Senior Living, Amedisys, Tenet Healthcare, and Encompass Health.
.